Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ATIS is on the move! -- Ignore unavailable to you. Want to Upgrade?

To: Jeff Jordan who wrote (2195)	5/23/2002 8:14:12 PM
From: Gary Stern	Read Replies (1) \| Respond to of 2205

I have a sincere dislike of current management. Their attitude is that the science will one day be recognized and everyone will be rich. Of course, in the interim, lets pay ourselves a lot of money. They figure that the worse that can happen is that someone buys them out and they get a golden parachute or a better deal with the acquirer. I think that Nouricel will be the savior of my investment. I believe that it will make significant revenue and when coupled with a marketable human collagen sold by Inamed, and Dermagraft sales, they will wind up marginally profitable. Having said the above, I confess that my annoyance with management is their refusal to self promote. At the earliest point that they can project revenues from profit centers they should act like the big boys and give us "guidance". This way the stock can be priced upon the expectation. Also, they need to put together an analyst road show and get out there and kiss ass. If they won't promote themselves its going to be a very long haul before we see any equity in our investment.